Large holder opposes $1.4B sale of Point Biopharma to Eli Lilly as it is not in the best interest of shareholders
https://seekingalpha.com/news/4031202-point-biopharma-quickly-gains-as-big-holder-comes-out-against-eli-lilly-deal
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.